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BRIEF REPORT
Prevalence of chronic obstructive pulmonary disease (COPD) among
rheumatoid arthritis: results from national inpatient database
Rashmi Dhital a, Sijan Basnet a, Prakash Paudelb, Yam Prasad Acharyac and Dilli Ram Poudel a
aInternal Medicine, Tower Health System, West Reading, PA, USA; bInternal Medicine, Berkshire Medical Center, Pittsfield, MA, USA;
cInternal Medicine, Miriam Hospital, Providence, RI, USA
ABSTRACT
Rheumatoid arthritis (RA) is being increasingly recognized as an important contributor to
chronic obstructive pulmonary disease (COPD). Although smoking is a major risk factor, other
factors may play a role. We used National Inpatient Sample (NIS) from 2013 to explore this
relationship. We used propensity matching with a 1:3 nearest-neighbor-matching algorithm
to match 1 RA hospitalization to 3 age- and-sex-matched comparators. In the age- and-sex-
matched population, RA had a higher odds of COPD (OR 1.20, 95% CI: 1.17–1.22, p < 0.0001).
RA is associated with increased COPD prevalence, independent of smoking. COPD might
fall within the spectrum of RA complications, likely due to autoimmune and inflammatory
mechanisms.
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1. Introduction
Chronic obstructive pulmonary disease (COPD)
refers to the limitation in airflow that is not fully
reversible [1]. There is a growing body of literature
suggesting that rheumatoid arthritis (RA) is asso-
ciated with an increased risk of incident COPD com-
pared to matched general population. Studies have
been carried out in various regions of the world-
Canada, Israel, Taiwan, Netherlands, Sweden and
Minnesota, all suggesting that COPD is more preva-
lent in RA [2–7]. Although smoking is known to be a
major risk factor for development and progression of
COPD, the presence of substantial number of COPD
patients who have never smoked suggests that other
factors may play a role, with inflammatory and
immune responses being important ones [8,9]. We
aimed to explore this relationship in an inpatient
setting, using a large inpatient database.
2. Material and methods
National Inpatient Sample (NIS) is the largest all- payer
publicly available inpatient care database in theUS,which
is a part of Healthcare cost and Utilization Project
(HCUP), and is sponsored by Agency of Healthcare
Research and Quality (AHRQ). It is a stratified 20%
sample of all discharges fromHCUP participating hospi-
tals and contains information on over 7 million hospital
discharges per year [10]. We selected all adults
(≥18 years) discharged from 1 January 2013 to 31
December 2013. We developed two age- and sex-
matched groups of patients: one with a diagnosis of RA
based on International Classification of Disease (ICD-9)
code(s) 714.x (714.0, 714.1, 714.2, 714.30, 714.31, 714.32,
714.33 and 714.81) and the other without a diagnosis of
RA. Matching was done with a 1:3 nearest-neighbor-
matching algorithm. Patients who had a diagnosis of
COPD were identified based on ICD-9 codes 491.x,
492.x and 496 (491.2, 491.20, 491.21, 491.22, 492, 4920,
4928 and 496). We calculated the odds of association of
RA with COPD by univariate and multivariate (control-
ling for covariates such as age, sex, race and smoking
status) analyses. Smoking status was identified based on
ICD-9 codes for current smoking as well as a history of
smoking. We used STATA version 13.0 for analysis.
Ethical clearance and patient consent was not
sought as the NIS HCUP database contains de-iden-
tified patient data.
3. Results
Baseline demographic characteristics of the hospitaliza-
tion groups before and after matching are listed in
Table 1. In the original (unmatched) group of
29,922,246 hospitalizations, RA (468,750; 1.57%) was
more common in Caucasians (76%) and females
(73.98%) with a mean age of 67.47 years. The rate of
smoking was higher in RA hospitalizations compared to
those without RA (28.88% vs 26.09%, p < 0.0001) and the
COPD prevalence was higher (21.12% vs 13.41%,
p < 0.0001). RA was associated with an increased
COPD prevalence, with an odds ratio (OR) of 1.28
(95% CI 1.26–1.31, p < 0.0001), even after multivariate
adjustment (Table 2).
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In the age and sex-matched population, we esti-
mated a total of 1,874,999 hospitalizations in 2013;
468,750 (25%) had RA and 1,406,249 (75%) made up
the comparator non-RA group. On univariate analy-
sis, RA hospitalizations had a 1.23 (95% CI 1.20–1.25,
p < 0.0001) times higher odds of having COPD.
Multivariate logistic model demonstrated that RA
was still associated with COPD, after controlling for
covariates including age, sex, race and smoking sta-
tus, with an OR of 1.20 (95% CI 1.17–1.22,
p < 0.0001) (Table 2). Smoking, by itself, was asso-
ciated with a significantly higher odds of COPD (aOR
3.82, 95% CI 3.74–3.91) in the adjusted analysis.
4. Discussion
Our findings suggest that RA is associated with an
increased COPD among in-patients, independent of
smoking. The mechanism of COPD in RA has been
suggested by prior studies to be autoimmune or
inflammatory, with cytokines and chemokines con-
tributing to lung tissue destruction [1,8,9]. Studies
looking at association of reduced lung function tests
with systemic inflammatory markers have shown that
COPD patients have higher levels of circulating
inflammatory markers including leukocytes, fibrino-
gen, ESR, CRP, tumor necrosis factor-α, suggesting
that systemic inflammation may have a role in COPD
[11]. Also, increased production of autoantibodies
against a broad spectrum of self-antigens has been
demonstrated in COPD, suggesting the role of auto-
immunity [12]. Authors from prior studies have also
pointed out the possibility of recurrent respiratory
infections in RA patients to predispose to airway
obstruction [13,14].
In the setting of possible autoimmune contribu-
tion to COPD, authors have suggested that RA-
related immune dysfunction could trigger abnor-
mal inflammatory response in the airway, with
higher likelihood of COPD. The other mechanism
that has been postulated is that the chronic
inflammation in RA may lead to alveolar wall
destruction by effect on alveolar epithelial cells,
ultimately leading to COPD [15] There are studies
that have looked at the pulmonary function tests
in patients with RA have suggested that RA
patients had significantly lower values of FEV1,
FVC, and FEV1/FVC- which are the indicators of
obstructive lung disease [13,14]. Although
restrictive lung disease (interstitial lung disease)
is well recognized in RA, the association with
COPD has only been evaluated by a handful of
studies. Diagnosis of COPD in RA patients may
often be delayed due to subtle and non-specific
early symptoms, which may be further masked due
to restricted mobility from joint disease. The find-
ing of our study is in line with the conclusion by
some prior studies [2–7].
The major strength of this study is the large sam-
ple size, which is representative of almost 95% of US
hospitalizations. The limitations include inaccuracies
in the coding inherent to the administrative data-
bases, lack of patient level data such as quantification
of smoking and the results of the pulmonary function
test (PFT) tests.
5. Conclusion
COPD might fall within the spectrum of RA com-
plications and one should be vigilant about diag-
nosing COPD early in this subpopulation. Further
studies have a potential to detect if control of
COPD can be established as one of the treatment
targets among RA patients with COPD and help
direct how early effective therapy towards joint
disease may modify the subsequent risk of pul-
monary complications.
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